ArticleClinical drug investigation2005

Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery : Effects of Timing of First Dose and Risk Factors for Thromboembolism and Bleeding Complications on Efficacy and Safety.

Ola E Dahl et al.PubMed ↗Publisher ↗

No numbers read from the abstract.